title: Benefit-risk assessment: to quantify or not to quantify, that is the question.
authors.affiliation: Epidemiology, Johnson and Johnson Pharmaceutical Research and Development, Titusville, NJ, USA. zyuan6@its.jnj.com
authors.forename: Zhong
authors.initials: Z
authors.lastname: Yuan
authors.forename: Bennett
authors.initials: B
authors.lastname: Levitan
authors.forename: Jesse A
authors.initials: JA
authors.lastname: Berlin
mesh_terms: D002986:Clinical Trials as Topic / Q000379:methods; D017277:Drug Approval / Q000458:organization & administration*; D015195:Drug Design; D055808:Drug Discovery / Q000191:economics / Q000379:methods; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D004364:Pharmaceutical Preparations / Q000008:administration & dosage / Q000191:economics; D012107:Research Design
chemical_list: D004364:Pharmaceutical Preparations